Susanne Löfgren

Summary

Affiliation: AstraZeneca R and D

Publications

  1. ncbi Few alterations in clinical pathology and histopathology observed in a CYP2C18&19 humanized mice model
    Susanne Löfgren
    Safety Assessment Sweden, AstraZeneca R and D Sodertalje, S 151 85 Södertälje, Sweden
    Acta Vet Scand 50:47. 2008
  2. ncbi Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormone
    Susanne Löfgren
    Safety Assessment Sweden, AstraZeneca R and D, Department of Pathology, B681 2, 15185 Södertälje, Sweden
    Drug Metab Dispos 37:1505-12. 2009

Detail Information

Publications2

  1. ncbi Few alterations in clinical pathology and histopathology observed in a CYP2C18&19 humanized mice model
    Susanne Löfgren
    Safety Assessment Sweden, AstraZeneca R and D Sodertalje, S 151 85 Södertälje, Sweden
    Acta Vet Scand 50:47. 2008
    ..This study was performed to characterize a gene-addition transgenic mouse containing a BAC (bacterial artificial chromosome) clone spanning the human CYP2C18&19 genes (tg-CYP2C18&19)...
  2. ncbi Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormone
    Susanne Löfgren
    Safety Assessment Sweden, AstraZeneca R and D, Department of Pathology, B681 2, 15185 Södertälje, Sweden
    Drug Metab Dispos 37:1505-12. 2009
    ....